West Pharmaceutical Services (WST) Shares Repurchased (2009 - 2026)

West Pharmaceutical Services has disclosed Shares Repurchased across 15 years of filings, most recently posting $297.6 million for Q1 2026.

• Shares Repurchased for Q1 2026 came in at $297.6 million, up 122.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $298.1 million (down 30.25% YoY), and the FY2025 annual result was $134.0 million, down 76.11% from the prior year.
• Shares Repurchased came in at $297.6 million for Q1 2026 at West Pharmaceutical Services, up from $500000.0 in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $297.6 million in Q1 2026 to a low of -$100000.0 in Q4 2022.
• The 5-year median for Shares Repurchased is $60.1 million (2023), against an average of $108.9 million.
• Across the five-year window, Shares Repurchased soared 177100.0% in 2023 and tumbled 99.73% in 2025, its largest moves.
• West Pharmaceutical Services' Shares Repurchased stood at -$100000.0 in 2022, then jumped by 177100.0% to $177.0 million in 2023, then tumbled by 69.27% to $54.4 million in 2024, then slumped by 99.08% to $500000.0 in 2025, then surged by 59420.0% to $297.6 million in 2026.
• The last three Shares Repurchased figures came in at $297.6 million (Q1 2026), $500000.0 (Q2 2025), and $133.5 million (Q1 2025), per Business Quant data.